A Trial to Evaluate Efficacy of Heart-protecting Musk Pill
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 2700 participants.
Also called NCT01897805
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 2,700 participants
- Registry
-
NCT01897805
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- China
- Registry status
- Unknown status
Technical summary
Registry record NCT01897805. Randomized; quadruple masking; primary purpose treatment. Start 2011-07 (registry gives no type); primary completion 2015-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Trial to Evaluate Efficacy of Heart-protecting Musk Pill
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Heart-protecting Musk Pill
- Intervention (Drug)
- Placebo
- Lead sponsor
- Shanghai Hutchison Pharmaceuticals Limited
Record details
- Record id
cardio:ct-nct01897805- Content hash
83d770fd49c86b837d297ff3e61314e908f6bf4b41b84a26ac64cf81d474fa32